trial · primary record
Nelfinavir
Myelofibrosis
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2027-06 |
| Primary endpoint | Change in Hepcidin Levels |
| Registry ID | NCT07281781 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:10.002Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07281781
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.